De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice

被引：0
|
作者：
Arenas, A. [1 ,2 ,3 ]
Moreta, M. J. [4 ]
Ordas, I. [1 ,4 ]
Fernandez-Clotet, A. [1 ,4 ]
Caballol, B. [1 ,4 ]
Gallego, M. [1 ,4 ]
Vara, A. [1 ,4 ]
Barastegui, R. [1 ,4 ]
Giner, A. [1 ,4 ]
Prieto, C. [1 ,4 ]
Masamunt, M. C. [1 ,4 ]
Ricart, E. [1 ,4 ]
机构：
[1] Hosp Clin Barcelona, Inflammatory Bowel Dis Unit, Barcelona, Spain
[2] Complejo Asistencial Dr Sotero del Rio, Unidad Gastroenterol, Santiago, Chile
[3] Univ Desarrollo, Fac Med Clin Alemana, Santiago, Chile
[4] Hosp Clin Barcelona, Gastroenterol, Barcelona, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P697
引用
收藏
页码：829 / 831
页数：3
相关论文
共 50 条
  • [1] De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice
    Arenas, Alex
    Moreta, Maria Jose
    Ordas, Ingrid
    Fernandez-Clotet, Agnes
    Caballol, Berta
    Gallego, Marta
    Vara, Alejandro
    Barastegui, Rebeca
    Giner, Angel
    Prieto, Cristina
    Masamunt, Maria Carme
    Candia, Roberto
    Ricart, Elena
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (07): : 673 - 682
  • [2] A User's Guide to De-Escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease
    Arebi, Naila
    Dyall, Lovesh
    Kamperidis, Nik
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (06) : 1300 - 1301
  • [3] A User's Guide to De-escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease
    Hirten, Robert P.
    Lakatos, Peter L.
    Halfvarson, Jonas
    Colombel, Jean Frederic
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) : 1336 - 1345
  • [4] A User's Guide to De-Escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease Reply
    Hirten, Robert P.
    Lakatos, Peter L.
    Halfvarson, Jonas
    Colombel, Jean-Frederic
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (06) : 1301 - 1302
  • [5] Perspectives From Patients and Gastroenterologists on De-escalating Therapy for Crohn's Disease
    Siegel, Corey A.
    Thompson, Kimberly D.
    Walls, Danielle
    Gollins, Jan
    Buisson, Anne
    Olympie, Alain
    Beaugerie, Laurent
    Colombel, Jean-Frederic
    Louis, Edouard
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (02) : 403 - 405
  • [6] A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+breast cancer
    Esposito, Angela
    Viale, Giulia
    Criscitiello, Carmen
    Curigliano, Giuseppe
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (01) : 9 - 16
  • [7] DE-ESCALATING THERAPY IN PATIENTS WITH CROHN'S DISEASE RECEIVING ADALIMUMAB: SUBGROUP ANALYSIS OF THE CALM STUDY
    Bossuyt, P.
    D'Haens, G.
    Panaccione, R.
    Sandborn, W.
    Reinisch, W.
    Travis, S.
    Schreiber, S.
    Armuzzi, A.
    Danese, S.
    Berg, S.
    Petersson, J.
    Maa, J-F
    Neimark, E.
    Colombel, F.
    GUT, 2019, 68 : A70 - A71
  • [8] Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice
    Bruscoli, Stefano
    Febo, Marta
    Riccardi, Carlo
    Migliorati, Graziella
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Evaluating the impact of de-escalating antimicrobial therapy in burn patients: a retrospective cohort study
    Kohama, Y.
    Kosugi, M.
    Arakawa, M.
    Hidaka, S.
    PHARMAZIE, 2022, 77 (10): : 311 - 315
  • [10] Clinical and economic benefits of de-escalating stress ulcer prophylaxis therapy in the intensive care unit: A quality improvement study
    Anstey, Matthew H.
    Litton, Edward
    Palmer, Robert N.
    Neppalli, Sneha
    Tan, Benedict J.
    Hawkins, David J.
    Krishnamurthy, Ravi B.
    Jacques, Angela
    Sonawane, Ravikiran V.
    Chapman, Andrew R.
    Norman, Richard
    ANAESTHESIA AND INTENSIVE CARE, 2019, 47 (06) : 503 - 509
12345